| 22.25 Delayed Data As of Nov 16 |  -0.37 / -1.64%Today’s Change | 12.40 Today|||52-Week Range 25.96 | +17.41% Year-to-Date |
| Regeneron (REGN) Rides on Eylea and Dupixent's Performance Nov 16 / Zacks.com - Paid Partner Content | Momenta (MNTA) Reports Narrower-Than-Expected Loss in Q3 Nov 09 / Zacks.com - Paid Partner Content |
| BlueMountain Capital Management, LLC Buys PG&E Corp, Hanger Inc, Ensco PLC, Sells BP ... Nov 15 / GuruFocus News - Paid Partner Content | Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes Nov 07 / Zacks.com - Paid Partner Content |
| Lilly Offers Updates on Progress of Headache Disorder Drugs Nov 15 / Zacks.com - Paid Partner Content | Is Teva Pharmaceutical Industries (TEVA) Outperforming Other Medical Stocks This Year... Nov 07 / Zacks.com - Paid Partner Content |
| BioDelivery (BDSI) Q3 Earnings Beat, Sales In Line, Stock Up Nov 12 / Zacks.com - Paid Partner Content | Lilly (LLY) Tops Q3 Earnings, Lifts 2018 Outlook, Stock Up Nov 06 / Zacks.com - Paid Partner Content |
| Previous close | 22.62 |
| Today’s open | 22.49 |
| Day’s range | 22.12 - 22.83 |
| Volume | 9,454,689 |
| Average volume (3 months) | 11,472,727 |
| Market cap | $23.0B |
| Earnings growth (last year) | -23,426.50% |
| Earnings growth (this year) | -27.03% |
| Earnings growth (next 5 years) | -1.65% |
| Revenue growth (last year) | +2.60% |
| P/E ratio | NM |
| Price/Sales | 0.85 |
| Price/Book | 1.68 |
| Today’s change | Today’s % change | |
|---|---|---|
| BGNEBeiGene Ltd | +0.02 | +0.02% |
| AKRXAkorn Inc | -0.10 | -1.44% |
| OASMOasmia Pharmaceutica... | -0.17 | -3.37% |
| Next reporting date | February 7, 2019 |
| EPS forecast (this quarter) | $0.55 |
| Annual revenue (last year) | $22.5B |
| Annual profit (last year) | -$16.4B |
| Net profit margin | -72.66% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Kåre Schultz |
Executive Vice President- Global Operations Carlo de Notaristefani |
Corporate headquarters Petach Tikva, Hamerkaz |
